Sarepta Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:SRPT Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
12 Mar 26	SellUS$123,208	Stephen Mayo	Individual		7,239	US$17.02
16 Dec 25	SellUS$294,202	Ian Estepan	Individual		13,187	US$22.31

Insider Trading Volume

Insider Buying: SRPT insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of SRPT?
Owner Type	Number of Shares	Ownership Percentage
State or Government	81,680	0.0756%
Individual Insiders	4,354,060	4.03%
Hedge Funds	6,341,284	5.87%
Institutions	97,268,236	90%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 76.63% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14%	BlackRock, Inc.	14,754,917	US$247.9m	3.3%	no data
6.29%	Vanguard Portfolio Management, LLC	6,640,692	US$111.6m	1,280%	0.01%
6.26%	State Street Global Advisors, Inc.	6,613,314	US$111.1m	0.21%	no data
6.01%	AQR Capital Management, LLC	6,341,284	US$106.5m	-17.4%	0.05%
4.35%	Two Sigma Investments, LP	4,593,195	US$77.2m	88.1%	0.06%
4.34%	Vanguard Capital Management, LLC	4,578,235	US$76.9m	0%	no data
3.92%	First Trust Advisors LP	4,135,788	US$69.5m	108%	0.04%
3.7%	RA Capital Management, L.P.	3,902,596	US$65.6m	0%	0.85%
3.05%	Richard Barry	3,216,667	US$54.0m	0.07%	no data
2.81%	Erste Asset Management GmbH	2,968,945	US$49.9m	8.79%	0.36%
2.38%	UBS Asset Management AG	2,509,414	US$42.2m	7.92%	no data
2.2%	Aberdeen Group Plc	2,318,890	US$39.0m	2.99%	0.02%
2.02%	Bank of America Corporation	2,133,510	US$35.8m	29.6%	0.01%
1.99%	Morgan Stanley	2,102,337	US$35.3m	48.4%	no data
1.88%	Geode Capital Management, LLC	1,988,796	US$33.4m	4.44%	no data
1.69%	Federated Hermes, Inc.	1,786,021	US$30.0m	36%	0.05%
1.58%	Renaissance Technologies LLC	1,665,078	US$28.0m	43.6%	0.04%
1.36%	Millennium Management LLC	1,436,269	US$24.1m	39.4%	0.01%
1.18%	Canada Pension Plan Investment Board	1,242,800	US$20.9m	258%	0.01%
1.17%	T. Rowe Price Group, Inc.	1,236,595	US$20.8m	25.9%	no data
1.09%	Citigroup Inc.	1,147,648	US$19.3m	0.13%	0.01%
0.97%	Connor, Clark & Lunn Investment Management Ltd.	1,019,951	US$17.1m	-5.8%	0.03%
0.85%	Susquehanna International Group, LLP	897,532	US$15.1m	110%	0.01%
0.82%	Legal & General Investment Management Limited	866,743	US$14.6m	228%	no data
0.76%	Voleon Capital Management LP	800,660	US$13.5m	-9.01%	0.28%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/05/26 16:36
End of Day Share Price	2026/05/22 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sarepta Therapeutics, Inc. is covered by 50 analysts. 21 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Brian Skorney	Baird
Huidong Wang	Barclays
Eliana Merle	Barclays